Medindia

X

Genomma Lab 3Q09 Conference Call Invitation

Friday, October 16, 2009 General News J E 4
Advertisement

MEXICO CITY, Oct. 15 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B de C.V. (BMV: LAB) will release its Third Quarter 2009 earnings results after the market close on Monday, October 26, 2009. Mr. Rodrigo Herrera Aspra, CEO of Genomma Lab Internacional, and members of management will host a conference call on Tuesday, October 27, 2009 at 12:00 p.m. ET; (10:00 a.m. Mexico City) to discuss the quarterly earnings and provide an update on Genomma's business.

The conference call telephone numbers are 973-582-2700 for international participants, 001-800-514-0821 for participants in Mexico and 888-562-3356 for U.S. participants.

Participants should dial in 10 minutes prior to the scheduled start of the call. The passcode to access the call is 32483260.

About Genomma

Genomma Lab Internacional, S.A.B. de C.V. is one of the fastest-growing pharmaceuticals and personal care products companies in Mexico, with an increasing international presence. Genomma trades on the Mexican Stock Exchange under the ticker symbol LAB. Genomma Lab's shares are listed on the Mexican Stock Exchange under the ticker symbol "LAB.B" (Bloomberg: labb.mx).

For additional corporate information, please visit the Company's web site at: www.genommalab.com.

Genomma Lab Internacional, S.A.B de C.V. press releases and all other written materials may from time to time contain statements about expected future events and financial results that are forward-looking and subject to risks and uncertainties. Forward-looking statements involve inherent risks and uncertainties. We caution you that a number of important factors can cause actual results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in such forward-looking statements. These factors include economic and political conditions and government policies in Mexico or elsewhere, including changes in inflation rates, exchange rates, regulatory developments, customer demand and competition.

    IR Contact: Oscar Villalobos
    Tel: +52 (55) 5081-0000 ext. 4250
    E-mail: inversion@genommalab.com

    In New York: i-advize Corporate Communications, Inc.
    Tel: (212) 406-3692
    E-mail: genomma@i-advize.com

SOURCE Genomma Lab Internacional, S.A.B de C.V.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
178 Strong, Maine State Troopers Team Represented ...
S
Verathon Introduces the GlideScope(R) Cobalt Advan...